Curated coverage for food-industry with top developments, timeline context, and connected threads.
Protein-enriched products are flooding the market as GLP-1 drug users and longevity-focused consumers drive demand. Here is the science behind protein's growing status and who is profiting.
EuroBulletin24 Editorial Desk | Linked source
Ozempic users eat significantly less. With millions on GLP-1 drugs, food companies are reformulating products for smaller servings. Here is the specific business transformation happening.